ly3537021
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 23, 2020 (NCT04586907)
Timeline
Indications
Mechanism of action
GIPR agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07169851 | Phase 2 | Oct 31, 2025 | Eli Lilly |
| NCT05444569 | Phase 1 | Aug 8, 2022 | Eli Lilly |
| NCT04586907 | Phase 1 | Nov 23, 2020 | Eli Lilly |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eli Lilly | For profit | 3 | 3 | 2 | 2020 |
1 organizations
Page 1 / 1